- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The Arts-Sciences Workshop, a common innovation initiative between CEA-Grenoble and the Hexagone Scène Nationale de Meylan, in partnership with the Cultural Center for Scientific and Industrial Engineering (CCSTI) in Grenoble, has issued a call for projects.
The 2011 Art.Research.Technology.Science prize is open to an international audience for the first time.
It will reward projects that cross the artistic, technological, and scientific domains in three research areas of CEA/Grenoble:
- New energy technologies for transportation, mobile electronics, solar energy, energy storage and nano-materials
- New technologies for information and communication, microsystems, imaging, lighting, display and bio/health
- Living and materials sciences
The winner will receive a research partnership with a CEA laboratory and a cash award of 30,000 euros to be used in the fulfilment of the project. For this third year of the prize, the Arts-Sciences Workshop has expanded its offer to include a second prize, a jury's pick and a special reward for students.
The deadline for entries is May 18, 2011. Prizes will be awarded in October at the Rencontres-I, Biennial Arts-Sciences 2011.
CEA is a French research and technology organization, with activities in four main areas: energy, information technologies, healthcare technologies and defense and security. Within CEA, the Laboratory for Electronics & Information Technology (CEA-Leti) works with companies in order to increase their competitiveness through technological innovation and transfers. CEA-Leti is focused on micro and nanotechnologies and their applications, from wireless devices and systems, to biology and healthcare or photonics. Nanoelectronics and microsystems (MEMS) are at the core of its activities. As a major player in MINATEC campus, CEA-Leti operates 8,000-m2 state-of-the-art clean rooms, on 24/7 mode, on 200mm and 300mm wafer standards. With 1,400 employees, CEA-Leti trains more than 150 Ph.D. students and hosts 200 assignees from partner companies. Strongly committed to the creation of value for the industry, CEA-Leti puts a strong emphasis on intellectual property and owns more than 1,500 patent families.
About HEXAGONE SCENE NATIONALE DE MEYLAN
Since 1989, Hexagone Scène Nationale in Meylan has been dedicated to providing support for the creative process and promotion of performing arts. Being an artistic production venue of reference, it contributes to all fields of contemporary culture: theatre, dance, music, circus and other emerging forms while organizing their intersection and their promotion. Since 2002, Hexagone Scène Nationale in Meylan has also been developing a mission in research, firstly by conceiving and convening the Rencontres-i Festival, an Arts-Sciences-Corporations biennial and secondly, by having put in place a workshop, entitled Atelier Arts-Sciences, in 2007. The Hexagone team includes 18 people and plays host to over a hundred shows per year in its 560 seat auditorium receiving over 30,000 spectators per season. www.theatre-hexagone.eu
For more information, please click here
+33 4 38 78 29 87
+33 1 58 18 59 30
Copyright © CEA-LetiIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Making new materials with micro-explosions: ANU media release: Scientists have made exotic new materials by creating laser-induced micro-explosions in silicon, the common computer chip material June 29th, 2015
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
X-rays and electrons join forces to map catalytic reactions in real-time: New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions June 29th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015